Abstract IA08: Personalizing HNSCC treatment based on TP53 mutational status
Sign Up to like & getrecommendations! Published in 2017 at "Clinical Cancer Research"
DOI: 10.1158/1557-3265.aacrahns17-ia08
Abstract: Head and neck squamous cell carcinoma (HNSCC) is a leading cause of cancer deaths worldwide, and resistance to standard treatments with radiation/chemotherapy accounts for the majority of HNSCC deaths. Mutation of TP53 occurs in 60-85%… read more here.
Keywords: tp53 mutational; hnscc; mutational status; cancer ... See more keywords